V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001289 | 240011089 | 1.6 | 54 | null | null | 2019-01-05 | null | null | null | HYDROXYCARBAMIDE | 100756944 |
| 240001304 | 240011091 | null | null | null | null | 2019-07-30 | null | 02 | null | AML18 TRIAL | 100407630 |
| 240001319 | 240011092 | 1.69 | 84.5 | Palliative (P) | null | 2019-11-21 | null | 01 | N | BENDAMUSTINE + RITUXIMAB | 101043596 |
| 240001326 | 240011093 | 1.57 | 75.15 | Curative (C) | 2021-09-20 | 2021-09-22 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 101116854 |
| 240001336 | 240011094 | 1.68 | 72.2 | null | 2019-04-24 | 2019-04-24 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100327434 |
| 240001349 | 240011096 | 1.91 | 47.8 | Adjuvant (A) | null | 2019-03-11 | null | 01 | null | AZACITIDINE | 101393881 |
| 240001354 | 240011097 | 1.82 | 87.8 | Palliative (P) | null | 2018-10-24 | null | null | N | METHOTREXATE | 101747465 |
| 240001364 | 240011098 | 1.7 | 83 | Palliative (P) | null | 2020-02-16 | null | null | N | HYDROXYCARBAMIDE | 101067219 |
| 240001405 | 240011102 | 1.52 | 66.75 | Adjuvant (A) | null | 2021-05-08 | null | N | N | AML19 TRIAL | 100762947 |
| 240001430 | 240011103 | 1.79 | 71.9 | 03 | null | 2020-03-15 | null | N | null | METHOTREXATE | 101367622 |
| 240001436 | 240011104 | 1.73 | 54.7 | null | null | 2020-05-03 | null | 02 | null | AML19 TRIAL | 100913396 |
| 240001458 | 240011105 | 1.59 | 81.6 | Curative (C) | null | 2022-04-28 | null | null | N | RITUXIMAB | 100801410 |
| 240001465 | 240011106 | 1.64 | 89.8 | null | 2018-09-03 | 2018-09-03 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100985517 |
| 240001468 | 240011107 | 1.24 | 54.2 | 03 | null | 2021-02-15 | null | null | N | AZACITIDINE | 100515500 |
| 240001478 | 240011108 | null | null | 03 | 2020-10-06 | 2020-10-06 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101465867 |
| 240001525 | 240011112 | 1.68 | 117.5 | Adjuvant (A) | 2019-06-05 | 2019-08-01 | Rituximab (SUBCUTANEOUS Maintenance) | 01 | N | RITUXIMAB | 101430017 |
| 240001526 | 240011113 | 0 | 37.2 | Curative (C) | null | 2020-07-24 | ALL UKALL2011 Maintenance A2 | null | null | TRIAL | 100399158 |
| 240001539 | 240011114 | 1.64 | null | Disease modification (D) | null | 2016-09-17 | IBRUTINIB | null | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101163127 |
| 240001628 | 240011118 | 1.62 | 82 | Curative (C) | 2022-04-13 | 2022-04-29 | null | 02 | null | FLAG + IDARUBICIN | 100519114 |
| 240001645 | 240011119 | 1.52 | 31.6 | null | 2019-01-15 | 2019-04-20 | null | 02 | null | FLUDARABINE + THIOTEPA + TREOSULFAN | 100762540 |
| 240001667 | 240011120 | 1.81 | 54.8 | null | null | 2022-05-01 | ALL Interim Guide 2019 Maintenance | 01 | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 101239835 |
| 240001749 | 240011121 | 1.66 | 71.5 | Palliative (P) | null | 2019-02-26 | AML Int Guide HD Cytarabine (3 + 4) | null | N | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 101345435 |
| 240001809 | 240011123 | 1.72 | 84.49 | Curative (C) | 2020-08-28 | 2020-08-31 | Bortezomib + Thalidomide +/- Dex | 02 | null | CARBOPLATIN + ETOPOSIDE + VINCRISTINE | 100465468 |
| 240001818 | 240011125 | 1.63 | 91.8 | Curative (C) | 2022-04-16 | 2022-05-01 | null | 02 | N | BEACOPP | 101189206 |
| 240001837 | 240011126 | 1.84 | 54.9 | null | 2022-04-15 | 2022-05-01 | LENALIDOMIDE | 02 | null | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100257094 |
| 240001877 | 240011127 | 1.76 | 88.6 | null | 2019-09-20 | 2019-09-21 | DA-EPOCH-R | 02 | null | GEMTUZUMAB OZOGAMICIN | 100172582 |
| 240001888 | 240011128 | 1.77 | 69.7 | Curative (C) | 2022-02-19 | 2022-02-19 | NORDIC | N | null | R CODOX M | 100524121 |
| 240001892 | 240011129 | 1.63 | 128.6 | null | 2020-10-05 | 2020-10-05 | FLAG + Idarubicin | N | null | CHLORAMBUCIL + OBINUTUZUMAB | 100899672 |
| 240001895 | 240011130 | 1.78 | 7.6 | null | null | null | PENTOSTATIN + RITUXIMAB | null | null | AML MYECHILD 01 TRIPLE IT | 100246995 |
| 240001922 | 240011132 | 1.56 | 62.3 | null | null | 2020-01-14 | Midostaurin | null | null | AML MYECHILD 01 FLA-IDARUBICIN | 101630483 |
| 240001964 | 240011134 | 1.67 | 82.8 | null | 2017-08-03 | 2017-08-12 | CYTARABINE + DAUNORUBICIN | 02 | null | CYTARABINE HIGH DOSE | 101222255 |
| 240002001 | 240011137 | 1.76 | 55.9 | null | 2017-02-25 | 2017-03-02 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | IMATINIB | 101671093 |
| 240002034 | 240011141 | 1.54 | 76 | null | 2019-08-21 | 2019-08-31 | null | 02 | null | ABVD | 100494626 |
| 240002063 | 240011145 | 1.8 | 80.8 | Curative (C) | null | 2018-11-28 | Vinblastine | null | N | ALL UKALL2011 MAINTENANCE | 100752132 |
| 240002093 | 240011146 | 1.63 | 67 | null | 2017-02-08 | 2017-02-08 | LCH RELAPSE Dabrafenib | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100488667 |
| 240002136 | 240011148 | 0 | 0 | Curative (C) | 2021-08-01 | 2021-08-05 | RUXOLITINIB | 02 | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101441200 |
| 240002152 | 240011149 | 1.83 | 94 | null | 2019-12-11 | 2019-12-19 | null | 02 | N | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 100343792 |
| 240002153 | 240011150 | null | null | Palliative (P) | 2021-08-19 | 2021-08-22 | DABRAFENIB | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100732469 |
| 240002174 | 240011154 | 1.13 | 11.75 | null | 2021-11-08 | 2021-11-08 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | GEMTUZUMAB OZOGAMICIN | 100903268 |
| 240002188 | 240011155 | 0 | 63.4 | null | 2019-10-30 | 2019-11-25 | AML Interim Guidelines FLAG-Ida | 01 | null | STS NON-RHABDO EPSSG 2005 VBL/MTX | 100775225 |
| 240002189 | 240011156 | 1.5 | 66 | 03 | 2020-05-25 | 2020-05-25 | Mini BEAM | 02 | null | BRENTUXIMAB | 100197632 |
| 240002206 | 240011157 | 1.66 | 70.8 | 03 | 2020-09-06 | 2021-02-07 | AML Interim Guidelines FLAG-Ida | 02 | null | GEMTUZUMAB OZOGAMICIN | 101859904 |
| 240002224 | 240011158 | 1.63 | 52.6 | null | 2021-04-07 | 2021-04-15 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | DABRAFENIB | 100606828 |
| 240002241 | 240011159 | 1.62 | 17.3 | null | 2019-09-09 | 2019-09-09 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | IMATINIB | 100540022 |
| 240002287 | 240011163 | 1.83 | 71 | Disease modification (D) | 2017-11-02 | 2017-11-04 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101567333 |
| 240002298 | 240011164 | 1.89 | 0 | null | 2021-11-22 | 2021-11-27 | DABRAFENIB + TRAMETINIB | N | null | RUXOLITINIB | 100054492 |
| 240002326 | 240011165 | 1.68 | 14.7 | null | 2022-05-24 | 2022-05-25 | Midostaurin | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101104111 |
| 240002350 | 240011166 | 1.76 | null | null | 2020-04-04 | 2020-04-22 | null | 02 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101108568 |
| 240002365 | 240011168 | 1.61 | 21.6 | null | null | 2016-10-07 | AML Downs IT Cytarabine | null | null | IBRUTINIB | 101217456 |
| 240002374 | 240011169 | 1.63 | 84 | null | 2020-06-25 | 2020-07-17 | Obinutuzumab + Venetoclax | N | null | CLADRIBINE | 100187681 |